三連板南方傳媒:粵教翔雲數字教材應用平台無教師直播授課功能
格隆匯2月10日丨南方傳媒(601900.SH)公佈,公司股票於2020年2月5日、2月6日、2月7日連續三個交易日收盤價格漲幅偏離值累計超過20%,根據《上海證券交易所交易規則》的有關規定,屬於股票交易異常波動情形,公司已於2020年2月8日披露了《南方出版傳媒股份有限公司股票交易異常波動公告》。2月10日公司股票再度漲停。
經公司董事會自查,公司開發的粵教翔雲數字教材應用平台主要為廣東省內(深圳除外)義務教育階段師生提供各版本數字教材及相關配套教育資源,主要供線下課堂使用,無視頻、音頻的實時交互功能,無教師直播授課功能。該項業務2018年已開始實施,對公司主營業務收入貢獻佔比1%左右。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.